In fact, the risk for progression from mild cognitive impairment to AD and cognitive decline is higher in subjects with elevated IL-6 and TNF-α levels in the cerebral spinal fluid (Heneka et al., 2015). The gene discussed is IL6; the disease is Alzheimer disease.